Skip to search formSkip to main contentSkip to account menu

Tenofovir:MCnc:Pt:Ser/Plas:Qn

Known as: Ténofovir:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique, Ténofovir:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif, ?????:????:????:??/??:?? 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSerumTenofovirUnit of Mass Concentration

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE ( TDF ) IN PATIENTS WITH CHRONIC HBV : WEEK 96 EFFICACY AND SAFETY RESULTS IN CHINESE PATIENTS ENROLLED IN 2 GLOBAL PHASE 3 STUDIES 1
IDDF2018-ABS-0113 Table 1 Subjects SOF/VEL/VOX 8 Weeks (n=611) SOF/VEL/VOX 
2018
2018
IDDF2018-ABS-0106 Tenofovir alafenamide (taf) compared with tenofovir disoproxil fumarate (tdf) in patients with chronic hbv: week 96 efficacy and safety results in chinese patients enrolled in 2…
Background TAF, a novel prodrug of tenofovir, has demonstrated efficacy noninferior to that of TDF at Week 48 in patients with… 
2016
2016
Actualité thérapeutique dans le VIH : le ténofovir alafénamide
Depuis l’apparition des premiers traitements contre le virus de l’immunodéficience humaine (VIH) en 1987, d’importantes avancées… 
2016
2016
VIH-19 - Comparaison randomisée, en double aveugle, de ténofovir alafénamide (TAF) vs ténofovir disoproxil fumarate (TDF), en association avec elvitégravir, cobicistat et emtricitabine (E/C/F) en…
2016
2016
VIH-15 - Ténofovir alafénamide en remplacement de ténofovir disoproxil fumarate chez des adultes en succès virologique
2015
2015
Infectious disease: New HIV-1 prodrug shows promise in phase III trials
The results of two randomized, double-blind, phase III, noninferiority trials show that a novel prodrug for initial HIV-1… 
2015
2015
Synthetic process of key intermediate of hemifumarate tenofovir alafenamide
The invention discloses a synthetic process of key intermediate of hemifumarate tenofovir alafenamide. A synthetic route is shown… 
2014
2014
Tenofovir during pregnancy in rats: a novel pathway for programmed hypertension in the offspring.
OBJECTIVES To evaluate the occurrence of systemic and renal abnormalities in the offspring of Wistar rats exposed to tenofovir… 
2013
2013
M-24 - Ténofovir/emtricitabine (TDF/FTC) + darunavir/ritonavir (DRV/r) en traitement de 1 re ligne : étude en vie réelle
2013
2013
Combination therapy comprising tenofovir alafenamide hemifumarate and cobicistat for use in the treatment of viral infections
(R) -2 - [[(S) - [[(S) -1- (isopropoxycarbonyl) ethyl] amino] phenoxyphosphinyl] methoxy] propyl} ] Adenine in the form of a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)